Ethinyl estradiol/norethindrone

DRUG2 trials

Sponsors

National Center for Research Resources (NCRR), Alexion Pharmaceuticals, Inc.

Conditions

HealthyHyperandrogenism

Phase 1

A Drug Interaction Study of Danicopan

CompletedNCT04709094

Alexion Pharmaceuticals, Inc.Healthy

Start: 2019-07-28End: 2020-04-17Updated: 2021-01-14

Phase 2

Phase II Randomized Study of Leuprolide Vs Oral Contraceptive Therapy Vs Leuprolide and Oral Contraceptive Therapy for Ovarian Hyperandrogenism

CompletedNCT00004763

National Center for Research Resources (NCRR)Hyperandrogenism

Start: 1993-01-31Target: 45Updated: 2005-06-24